THE EFFECT OF BETA GLUCAN OF SACCHAROMYCES CEREVISAE ON THE DECREASE OF ALPHA SYNUCLEIN EXPRESSION IN THE BRAIN SUBSTANTIA NIGRA OF PARKINSON’S WISTAR STRAIN RATS (Rattus novergicus) MODEL INDUCED WITH ROTENONE

Masruroh Rahayu, Shahdevi Nandar Kurniawan, Machlusil Husna, Hanestya Oky Hermawan
  MNJ, pp. 9-13  

Abstract


Background. One of the regenerative therapy modalities in Parkinson is using the beta glucan effect contained in Saccharomyces cerevisae.
Objective. To identify the effect of reduction in alpha synuclein expression on the brain substantia nigra in Parkinson's rat model after given Saccharomyces cerevisae.
Methods. This research applied true experimental design by in vivo with draft randomized post test only controlled group design. The sample was divided into five groups, each of them consisted of 5 rats. Variables measured were the decreasing level of alpha synuclein.
Results. There was a significant difference between positive control and negative control group.
Conclusion. The addition of Saccharomyces cerevisae is able to lower the alpha synuclein expression in Parkinson’s Wistar strain rat models significantly with maximum at the dose of 72 mg/kgBB.


Keywords


Alpha synuclein; Beta glucan; Parkinson; Sacchamycescerevisae

Full Text:

PDF

References


Lau, de LM, Breteler MM.. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006. 5:525-35.

Dorsey, ER, Kollet, O, Farke, Christian. 2007. Projected Number of People with Parkinson Disease in the Most Populous Nations, 2005 through 2030. Rochester, USA : Department of Neurology University of Rochester Medical Center. 2007 Jan 30; 68(5):384-386.

LeWitt, Peter A.. Levodopa for the Treatment of Parkinson’s Disease. Massachussets: New England Journal Medicine. 2008. 359:24682476.

Lotharius, Julie, Brundin, Patrik. Pathogenesis Of Parkinson`s Disease : Dopamine, Vesicles and α-Synuclein. Nature Reviews : Neuroscience. 2002. Vol. 3;1 – 11.,

Dauer, William, Przedborski, Serge. Parkinson`s Disease : Mechanisms and Models. Neuron. 2003.Vol. 39, 889–909.

Corselli, Mirko, Crisan, Mihaela, Lazzari, Lorenza Kovack. Perivascular Ancestor of Multipotent Stem cells.American Hearth Association JournalArterioscler Thromb Vasc Biol. 2010. 30:1104-1109.

Smith, Clayton. 2003. Hematopoietic Stem cells and Hematopoiesis. Blood marrow and transplant program. Florida: H.Lee Moffit Cancer Center.

Gierying A, Bogunia-Kubik K.. The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoieticstem cells to peripheral blood. Postepy Hig Med Dosw [Online]. 2007. 61:369–83.

Franzke A..The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev.2006.17:235–44.

Afzal, Aqeela, and Mocco, J. 2012. The Promise of Hematopoietic Stem cell Therapy for Stroke: Are We There Yet?, Advances in the Treatment of Ischemic Stroke, Dr. Maurizio Balestrino (Ed.), ISBN: 978-953-510136-9, InTech.

Hennemann, B., Ickenstein, G., Sauerbruch, S., Luecke, K., Haas, S., Horn, M., Andreesen, R., Bogdahn, U., Winkler, J.. Mobilization of CD34+ hematopoietic cells, colonyforming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy.2008. 10(3):303-11.

Pawitan, Jeanne Adiwinata. Prospect of Cell Therapy For Parkinson’s Disease.Acb Journal: Anat Cell Biol. 2011. 44:256-264.

Fardiaz, Srikandi. 1992. Mikrobiologi pangan 1. Jakarta : PT Gramedia Pustaka Utama ; 1992 : 254.

Sumarsih, Sri. 2003. Diktat Kuliah Mikrobiologi Dasar. Jurusan Ilmu Tanah Fakultas Pertanian Universitas UPN “Veteran”. Yogyakarta.

Sharma, Neha, & Bafna, Pallavi. Effect of Cynodon dactylon on rotenone induced Parkinson’s disease. Orient Pharm Exp Med. 2012. 12:167–175.

Yamada, M., Iwatsubo, T., Mizuno, Y., and Mochizuki, H.. Overexpression of α-synuclein in rat substantia nigra results in loss of dopaminergic neurons, Phosphorylation of asynuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson’s disease. Journal of Neurochemistry. 2004. 91, 451-461.

Carmeliet P, Ferreira V, Breier G. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996. 380(6573):435-439.

Brazelton, T.R., Rossi, F.M., Keshet, G.I., and Blau, H.M.. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000. 290, 1775–1779.

Meng, Xiaoyun, Munishkina, Larissa A., Fink, Anthony L., Uversky, Vladimir N..Effects of Various Flavonoids on the α-Synuclein Fibrillation Process. SAGE-Hindawi Access to Research Parkinson’s Disease. 2010. Volume 2010 Article ID 650794.


Refbacks

  • There are currently no refbacks.